Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

This study has been completed.
Information provided by (Responsible Party):
Celgene Corporation Identifier:
First received: October 18, 2007
Last updated: April 25, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2011
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 19, 2011